Edgewise Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Edgewise Therapeutics stock have a consensus rating of "Buy" and an average price target of $36, which forecasts a 18.27% increase in the stock price over the next year. The lowest target is $14 and the highest is $51.

Price Target: $36 (+18.27%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$14	$36	$42	$51
Change	-54.01%	+18.27%	+37.98%	+67.54%

Analyst Ratings

The average analyst rating for Edgewise Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	2	2	2	2	2	1
Buy	5	5	5	5	5	5
Hold	3	3	3	3	3	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Cory Kasimov Evercore ISI Group	Evercore ISI Group	Buy Maintains $30 → $45	Buy	Maintains	$30 → $45	+47.83%	Feb 27, 2026
Tessa Romero JP Morgan	JP Morgan	Buy Maintains $33 → $34	Buy	Maintains	$33 → $34	+11.70%	Nov 14, 2025
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $49 → $50	Buy	Maintains	$49 → $50	+64.26%	Nov 7, 2025
Laura Chico Wedbush	Wedbush	Buy Maintains $35 → $32	Buy	Maintains	$35 → $32	+5.12%	Nov 7, 2025
Paul Choi Goldman Sachs	Goldman Sachs	Hold Initiates $20	Hold	Initiates	$20	-34.30%	Sep 25, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

29.99M

EPS This Year

-2.03

from -1.63

EPS Next Year

-2.11

from -2.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	29.99M
Revenue Growth	-	-	-	-	-	-	-
EPS	-1.14	-1.26	-1.57	-1.45	-1.63	-2.03	-2.11
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	87.5M
Avg	n/a	30.0M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.79	-1.38
Avg	-2.03	-2.11
Low	-2.29	-2.70

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.